<DOC>
	<DOCNO>NCT01816555</DOCNO>
	<brief_summary>This study adult female newly diagnose breast cancer include surgery part standard cancer treatment . This research study combine Vitamin D ( counter medication ) standard care ( establish approve treatment ) , surgery . Evidence show woman Vitamin D3 deficient high risk breast cancer breast cancer recurrence . The purpose study find effect Vitamin D3 treatment period Stage I-II breast cancer . Screening test do determine subject eligible participate study . If subject eligible agree participate , assign one two group receive different amount vitamin D. Subjects ask keep medication diary . Subjects may remain treatment approximately 56 day .</brief_summary>
	<brief_title>Vitamin D3 ( Vit D3 ) Supplementation T Cell Immunomodulation Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Ductal , Breast</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Patients must great equal 18 year age . Patients must newly diagnose invasive ductal breast carcinoma , Stage III . Patients complete surgical radiation therapy . Patients must SWOG performance status 0 , 1 2 . Patients must adequate organ function define : Hgb &gt; 8.0 gm/dl , WBC &gt; 3,500 , platelet count &gt; 100,000 Bilirubin &lt; 2.0 mg/dl , SGOT &lt; 4x upper limit normal Creatinine &lt; 2.0 mg/dl calculate creatinine clearance &gt; 50 ml/min Patients must serum calcium phosphate product less 70 . Patients must recover prior surgery . Patients must willing use appropriate contraception childbearing potential . Patients may standard care maintenance dose Vit D3 Patients histology lobular carcinoma . Patients metastatic disease . Pregnant lactating woman . Male gender . Patients history sarcoidosis . Patients history idiopathic urinary calcium stone disease , chronic hypercalcemia , gastrointestinal malabsorptive condition . Patients receive follow treatment within last 14 day prior study registration exclude . Lithium Digitalis Thiazide diuretic Calcium supplementation 1,25dihydroxyvitamin D3 treatment Bisphosphonates Teriparatide Aluminum Hydroxide Bile Acid sequestrants Repletion dose VitD3 set know Vit D3 deficiency insufficiency Patients receive concurrent corticosteroid treatment within last 14 day prior study registration exclude . Known HIV positive . Patients active infection require antibiotic therapy . Other malignancy unless patient consider diseasefree 5 year prior randomization deem physician low risk recurrence . Patients follow cancer eligible diagnose treat within past 5 year : carcinoma situ cervix , carcinoma situ colon , melanoma situ , basal cell squamous cell carcinoma skin . Patients undergo neoadjuvant chemotherapy neoadjuvant endocrine therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>